Home > Category > Signaling Pathways > Neuronal Signaling > Amyloid-β > Donanemab

Donanemab

ChemLeader 95+%
Catalog No:CLA1552 CAS No.:1931944-80-7 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity

There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Donanemab
CAS1931944-80-7
Storage conditionstore at -20°C | Shipping with blue ice.
Product details

Donanemab (LY3002813) is a potent humanized IgG1 mAb targeting N-terminal pyroglutamate β-amyloid (Aβ), slowing tau progression and reducing amyloid in early Alzheimer's disease treatment.

Related literature

Donanemab in Early Alzheimer's Disease.

PMID: 33720637 DOI: 10.1056/NEJMoa2100708

Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays